InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PCT | Ann: Ongoing Disclosure Notice - Donald Huse | 22/03/19 | 0 | 25 | |||
|
|||||||
PCT | Ann: Updated Corporate Action Notice for Distribution | 22/03/19 | 0 | 25 | |||
|
|||||||
PCT | Ann: SPH Notice - Forsyth Barr Investment Management Limited | 21/03/19 | 0 | 26 | |||
|
|||||||
PCT | Ann: Initial Disclosure Notice - Ed Timmins | 20/03/19 | 0 | 25 | |||
|
|||||||
PCT | Ann: Amended SPH Notice - ANZ Bank New Zealand Limited | 14/03/19 | 0 | 153 | |||
|
|||||||
PCT | Ann: SPH Notice - ANZ Bank New Zealand Limited | 13/03/19 | 0 | 143 | |||
|
|||||||
PCT | Ann: Capital change notice of allotment | 11/03/19 | 0 | 193 | |||
|
|||||||
PCT | Ann: Precinct Retail Offer Closes Oversubscribed | 06/03/19 | 0 | 235 | |||
|
See All Discussions